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SummAry
haemangiopericytoma is a rare soft tissue tumour, with great histological variability and unpredictable clinical and biological behaviour. 
The precise cell type origin is uncertain. one third of haemangiopericytomas occur in the head and neck area, but only a few cases have 
been reported regarding localization at the parapharyngeal space. herewith, case is presented of a 54-year-old female, referred to our 
Department due to a parapharyngeal space tumour with non-specific imaging characteristics. The patient underwent radical excision of 
the tumour with a trans-cervical sub-mandibular approach. The histolopathologic examination revealed a neoplasm with the characteristic 
features of haemangiopericytoma. one year later, during the scheduled follow-up, the computerized tomography scan showed no evidence 
of recurrence or residual disease. The pre-operative evaluation of a haemangiopericytoma must include a thorough imaging evaluation with 
computerized tomography and magnetic resonance imaging, even if results may not be specific for haemangiopericytoma. Angiography 
and pre-operative embolization may be performed in cases of large tumours with significant vascularity. The treatment of choice is radical 
excision. The follow-up includes clinical evaluation every 6 months and annual magnetic resonance imaging for at least 3 years.
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riASSunTo
L’emangiopericitoma è un raro tumore delle parti molli di origine cellulare incerta, con alta variabilità istologica ed un comportamento 
clinico e biologico imprevedibile. Solamente un terzo dei casi esordisce nella regione cervico-facciale, mentre solo pochi casi sono stati 
riportati per quanto riguarda la localizzazione nello spazio parafaringeo. Presentiamo il caso di una paziente di 54 anni che è stata riferita 
al nostro Dipartimento con un tumore vascolare dello spazio parafaringeo di dimensioni 3,5 × 2,8 × 3 cm. Le caratteristiche fornite dalla 
diagnostica per immagini del tumore non erano specifiche. La paziente è stata sottoposta alla completa e radicale escissione del tumore 
tramite un approccio transcervicale-sottomandibolare. L’esame istopatologico ha rivelato una neoplasia con le caratteristiche dell’eman-
giopericitoma. Un anno dopo l’intervento, il follow-up effettuato con tomografia computerizzata ha dimostrato l’assenza di malattia 
ricorrente o residua. La valutazione preoperatoria dell’emangiopericitoma deve includere una dettagliata valutazione con diagnostica per 
immagini (tomografia computerizzata e risonanza magnetica), anche se i risultati possono non essere specifici. L’angiografia e l’emboliz-
zazione preoperatoria possono essere eseguiti in casi di grossi tumori altamente vascolari. Il trattamento di elezione è l’asportazione radi-
cale. Il follow-up comprende una valutazione clinica ogni 6 mesi e l’esecuzione di una risonanza magnetica annuale almeno per 3 anni.
PArole ChiAve: Tumori dello spazio parafaringeo • Emangiopericitoma • Tendine stilomandibolare
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Introduction
haemangiopericytoma (hPC) is a rare soft tissue tumour, 
which was first described, in 1942, by Stout and murray 1 2 
and was thought to originate from the pericyte, a specific 
cell type which surrounds the capillary vessels. however, 
the variable immunohistochemical profile of this tumour 
and its overlapping features with solitary fibrous tumours, 
created the belief that these two tumours are the two ends 
of one process, the origin of which is still unclear, ac-
cording to who endorsement. Despite the dispute, some 
investigators believe that hPCs arise from pluri-poten-
tial peri-vascular cells 3. Approximately one-third of all 
hPCs occur in the head and neck 4 and, according to the 
literature, only a few cases of hPCs, in the parapharyn-
geal space, have been described 5 6. hPCs are classified 
as benign, borderline, and malignant, depending on their 
histopathologic (mitotic activity, cellularity, and nuclear 
atypia) and clinical features (necrosis and tumour size) 7 8. 
however, histo-pathological distinction between benign haemangiopericytoma of the parapharyngeal space
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and malignant hPCs may be difficult. Furthermore, the 
biological behaviour of these neoplasms is rather peculiar, 
as benign-looking, non-mitotic hPCs have been reported 
to metastasize. given the high variability and the unpre-
dictable pattern of the clinical and biological behaviour 
of hPCs, the treatment of choice is radical surgical exci-
sion.
Case presentation
A 54-year-old female was referred to our Department from 
a hospital of a neighbouring country with the diagnosis of 
a para-pharyngeal space tumour. The presence of the tu-
mour had been detected 2 years previously in a CT scan, 
during the investigation of chronic headaches from which 
the patient suffered. it was located at the para-pharyngeal 
space and, according to the patient, the tumour had grown 
in size during the last 2 years. Six months before the pa-
tient’s admission to our Department, an incisional biopsy 
was attempted, in a hospital, in her country, but the opera-
tion was not completed due to severe bleeding.
The clinical examination revealed a neck mass behind the 
angle of the left mandible, which caused significant dis-
placement of the soft palate and the left tonsillar and peri-
tonsillar region towards the midline. upon palpation, the 
mass was fixed, soft, painless and non pulsatile. except 
for a retracting scar, at the site of the attempted biopsy, the 
rest of the clinical examination was normal.
The mri revealed an ovoid, well-defined tumour in the 
left parapharyngeal space 3.5 × 2.8 × 3 cm in size, which 
compressed  and  narrowed  the  oropharyngeal  opening. 
The tumour showed low signal intensity, on T1 sequenc-
es, mild dyshomogeneous hyperintensity on T2 sequenc-
es, inhomogenous low diffusivity, on diffusion weighted 
images (Fig. 1), as well as intense enhancement after in-
travenous gadolinium administration (Fig. 2). The mass 
also compressed the adjacent pterygoid muscles, but no 
evidence of an anatomic relationship with the major vas-
cular branches of the neck was detected.
The imaging characteristics of the tumour were non-spe-
cific. The differential diagnosis included highly vascu-
larized parapharyngeal space masses, like mesenchymal 
tumours (angiosarcoma, leiomyosarcoma) or neurinogen 
tumours.
After a thorough pre-operative evaluation, the patient 
underwent complete excision of the tumour, via a tran-
scervical-submandibular approach. A lateral neck inci-
sion was made just medially to the anterior margin of 
the  sternocleidomastoid  muscle,  which  was  extended 
to the level of the left parotid gland. Then, an anterior 
dislocation  of  the  mandible  through  stylo-mandibular 
tenotomy was performed, in order to provide sufficient 
exposure and ensure an adequate surgical field and the 
mass was removed to the level of the pharyngeal mus-
culature. Particular concern was focused on the site of 
the attempted biopsy, as the post-traumatic fibrosis and 
adhesions made the excision particularly difficult. After 
haemostasis, a Penrose drainage was placed and suture 
closure was performed.
The post-operative recovery was uneventful and the Pen-
rose drainage was removed on the 2nd post-operative day. 
The patient was finally dismissed on the 4th post-operative 
day.
The histolopathologic examination revealed a neoplasm 
with  the  histolopathological  and  immunohistochemical 
features of hPC, consisting of spindle and ovoid cells 
with mild nuclear atypia and low mitotic rate (up to 1 mi-
tosis/10 hPF). The neoplastic cells showed extensive reac-
tivity for CD34 and bcl2 and they were negative for SmA, 
S100, chromogranin and synaptophicine (Figs. 3, 4). As 
the tumour was removed in pieces, due to the presence of 
Fig. 1. MRI revealed an ovoid, well-defined mass in the left parapharyngeal 
space with mild inhomogeneous hyperintensity on T2 sequences (A), low 
signal intensity on T1 sequences (B) and inhomogeneous low diffusivity on 
diffusion weighted images (C) and ADC map (D).
Fig. 2. The tumour compressed and narrowed the oropharyngeal opening, 
characterized by intense enhancement after intravenous Gadolinium admin-
istration (A, B), implying high vascularization.e.n. Fountoulakis et al.
196
adhesions and particular friability of the mass, evaluation 
of the surgical margins was not possible.
one year later, during scheduled follow-up, the CT scan 
showed  no  evidence  of  recurrence  or  residual  disease 
(Fig. 5).
Discussion
A wide variety of benign and malignant tumours can oc-
cur in the parapharyngeal space. The management of a 
patient with such a tumour, represents a challenge for the 
head and neck Surgeon.
hPC is a neoplasm of uncertain cell type origin. it is 
an uncommon spindle cell tumour, constituting 2.5% of 
soft tissue neoplasms and occurs primarily in adult life 
(median age 45 yrs, with peak prevalence in the sixth to 
seventh decade of life), appearing with an equal sex dis-
tribution 9-11. it is frequently aggressive and has a tendency 
to recur and metastasize. Approximately one-third of all 
hPCs occur in the head and neck. Primary parapharyn-
geal space hPCs are very rare neoplasms and, according 
to the international literature, only a few cases have been 
reported, with some of them referring to tumours that 
invade the parapharyngeal space from other sites of the 
head and the neck 12.
A painless mass is the most common presentation of head 
and neck hPCs. The clinical behaviour varies depending 
on the different grading of each case. The diagnosis can-
not be made on the basis of clinical and gross morpholog-
ic characteristics. Definitive diagnosis of hPC is provided 
by the accurate histopathologic assessment, which deter-
mines the accurate management and prognosis 13. The pre-
diction of the clinical behaviour of hPC is not always clear 
and does not always correlate with the histolopathologic 
features of the tumour. Strict universal histopathologic 
criteria, for malignancy, have not been identified and vary 
between different studies. generally, large size (> 5 cm), 
increased mitotic rate (> 4 mitosis/10 hPF), with the pres-
ence of atypical mitosis, high cellularity, pleomorphic tu-
mour cells and foci of haemorrhage and necrosis predict a 
highly malignant course 8 13.
The correct pre-operative imaging evaluation of hPCs is 
of great importance for scheduling the surgical plan. The 
tumour usually appears as a solid mass, hypodense on CT 
and isointense on T1-weighted images on mri. on T2-
weighted images, the tumour shows equal or lower signal 
intensity compared with the surrounding structures, al-
though, in some cases, hyperintense signals have been de-
scribed 14. Due to better contrast resolution, mri is supe-
rior compared to CT in demonstrating the morphological 
characteristics of these tumours, as well as their extension 
to the contiguous anatomical structures, especially at the 
base of the skull. in these highly vascularized tumours, 
vessels could also be seen as signal voids, on mri, but 
not on CT. Although mri is essential for accurate surgical 
planning and should be referred as the “gold standard”, 
the imaging characteristics of the hPCs may be non-spe-
cific, demanding a differential diagnosis from other types 
of vascular or non-vascular tumours, especially those with 
Fig. 3. Microscopic view of haemangiopericytoma showing a circumscribed 
lesion, with the characteristic vascular pattern and a partial “staghorn” con-
figuration and spindle cell areas. (H&E, X 20)
Fig. 4. [A] High power view of the spindle cell areas. The spindle cells show 
no atypia, mitosis or necrosis. (H&E, X 400). [B] The spindle cells express 
cytoplasmic positivity in CD34 (immunohistochemistry, X 400).
Fig. 5. CT scan performed one year after the operation. No evidence of 
recurrence.haemangiopericytoma of the parapharyngeal space
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prominent vascularization, such as juvenile haemangioma, 
glomus tumour, angiosarcoma, leiomyoma, leiomyosar-
coma, schwannoma, mesothelioma, liposarcoma, benign 
and malignant histiocytoma, synovial sarcoma, chondro-
sarcoma, neuroblastoma, adenoid cystic carcinoma and 
mixed cell tumour 15 16.
Conventional  angiography  may  be  helpful  for  pre-op-
erative differential diagnosis and is useful for the possi-
bility of pre-operative embolization 5 17, which has been 
suggested as an option for decreasing tumour vascularity 
and size. moreover, some Authors use routine angiogra-
phy and peri-operative embolization in order to reduce 
intra-operative haemorrhage 18. in our patient, there was 
no need for such a procedure due to the small size of the 
tumour.
Although histopathology of hPCs has been well docu-
mented, fine-needle aspiration biopsy (FnAB) findings 
have rarely been described in the literature 19-21. A prima-
ry diagnosis of hPC is difficult to make with the use of 
FnAB. Cytologic analysis may allow the diagnosis of a 
recurrent or metastatic hPC 20.
in our Department, we do not advise incisional biopsy 
for tumours with considerable vascularity, due to the fear 
of bleeding and consequent fibrosis. Furthermore, we do 
not use FnAB because, these tumours will eventually be 
treated surgically, regardless of the pre-operative cytolog-
ic findings. FnAB may be particularly helpful in cases in 
which the suspicion of harbouring a malignancy is high.
The treatment of choice is radical excision of the hPC 
with a sufficient cuff of healthy tissue. unfortunately, this 
is not always possible for para-pharyneal space tumours, 
making the need of adequate exposure mandatory, which 
is accomplished by stylo-mandibular tenotomy.
Adjuvant  radiotherapy  and  chemotherapy  may  be  em-
ployed, although the literature is not quite clear about their 
results. hPCs are considered to be relatively resistant to 
radiotherapy. radiotherapy is reserved only as adjuvant 
therapy in cases of incompletely excised lesions, recur-
rent tumours, and tumours with high-grade histopatho-
logic features. Although chemotherapy may have a role in 
the treatment of distant metastatic disease, its role in the 
primary treatment remains to be clearly defined. vincris-
tine, Adriamycin, and Cyclophosphamide have all been 
used with variable success in cases of aggressive hPCs 
(8y10).  Some  additional  reports  show  that  the  use  of 
interferon may be of benefit in patients with pulmonary 
hPC metastases 22.
hPC appears to present a survival rate that may vary from 
an overall 10-year rate of 70% 8 to a considerably reduced 
10-year survival rate in cases of > 4 mitosis/10 hPF (9%) 
or necrosis (29%) or tumour size > 6.5 cm (63%) 9. Some 
studies report local recurrence rates as high as 40%, with 
metastatic disease in 15% of the cases 23 reported to have a 
latency period which varies from 63 to 107 months 24.
no  clear  consensus,  regarding  the  follow-up  planning, 
seems to exist. in our case, we propose clinical evaluation 
every 6 months and an annual imaging study for at least 
3 years. in our case, the patient performed a CT scan 1 
year after the operation with no evidence of recurrence or 
residual disease
Conclusions
haemangiopericytoma is a rare soft tissue tumour of un-
certain cell type origin, with high histological variability 
and unpredictable clinical and biological behaviour. one 
third of hPCs occur in the head and the neck and only a 
few cases have been reported regarding localization in the 
parapharyngeal space.
Pre-operative evaluation must include a thorough imaging 
evaluation (CT and mri scan), even if the results may not 
be specific for haemangiopericytoma. Angiography and 
pre-operative embolization may be performed in large tu-
mours with significant vascularity, in order to decrease the 
size and vascularity of the tumour.
The treatment of choice is radical excision, and the fol-
low-up we propose includes clinical evaluation every 6 
months and an annual mri for at least 3 years. incisional 
biopsy and pre-operative FnAB is not routinely used in 
our Department, due to the high incidence of bleeding and 
fibrosis and because, regardless of the histo-pathological 
pattern, total excision will eventually be performed. FnAB 
is advised when high suspicion of malignancy exists.
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